A high-level overview of Molecular Templates, Inc. (MTEMQ) stock. View (MTEMQ) real-time stock price, chart, news, analysis, analyst reviews and more.

Novel Oral Agent for ESR1-Mutated Breast Cancer Boosts PFS in Second-Line — PROTAC estrogen receptor degrader led to "clinically meaningful" improvement, investigator says ...